Materials and methods for treatment of allergic disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 28, 2009
Grant Date -
Sep 25, 2008
app pub date -
Feb 25, 2005
filing date -
Feb 25, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
siRNA molecules are disclosed which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells. The use of STAT6 specific siRNA molecules in the treatment of allergic diseases of the respiratory tract such as asthma and rhinitis is disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully